392
Participants
Start Date
January 31, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
tiotropium high dose
2 actuations once daily
placebo
2 actuations once daily
tiotropium low dose
2 actuations once daily
205.456.01004 Boehringer Ingelheim Investigational Site, Stockton
205.456.01008 Boehringer Ingelheim Investigational Site, Normal
205.456.01003 Boehringer Ingelheim Investigational Site, Baltimore
205.456.01007 Boehringer Ingelheim Investigational Site, Columbia
205.456.01002 Boehringer Ingelheim Investigational Site, Bellevue
205.456.01001 Boehringer Ingelheim Investigational Site, Rockville Centre
205.456.01005 Boehringer Ingelheim Investigational Site, Cincinnati
205.456.01006 Boehringer Ingelheim Investigational Site, Summerville
205.456.54002 Boehringer Ingelheim Investigational Site, Capital Federal
205.456.54006 Boehringer Ingelheim Investigational Site, Capital Federal
205.456.54008 Boehringer Ingelheim Investigational Site, Capital Federal
205.456.54005 Boehringer Ingelheim Investigational Site, Mendoza
205.456.54003 Boehringer Ingelheim Investigational Site, San Juan Bautista
205.456.54004 Boehringer Ingelheim Investigational Site, San Miguel de Tucumán
205.456.54009 Boehringer Ingelheim Investigational Site, San Miguel de Tucumán
205.456.61002 Boehringer Ingelheim Investigational Site, Parkville
205.456.61001 Boehringer Ingelheim Investigational Site, Perth
205.456.35902 Boehringer Ingelheim Investigational Site, Plovdiv
205.456.35901 Boehringer Ingelheim Investigational Site, Rousse
205.456.35903 Boehringer Ingelheim Investigational Site, Sofia
205.456.49008 Boehringer Ingelheim Investigational Site, Berlin
205.456.49001 Boehringer Ingelheim Investigational Site, Bochum
205.456.49004 Boehringer Ingelheim Investigational Site, Frankfurt
205.456.49005 Boehringer Ingelheim Investigational Site, Kehl
205.456.49003 Boehringer Ingelheim Investigational Site, Koblenz
205.456.49010 Boehringer Ingelheim Investigational Site, Mainz
205.456.49007 Boehringer Ingelheim Investigational Site, Neu-Isenburg
205.456.49002 Boehringer Ingelheim Investigational Site, Wesel
205.456.50201 Boehringer Ingelheim Investigational Site, Guatemala City
205.456.50203 Boehringer Ingelheim Investigational Site, Guatemala City
205.456.50204 Boehringer Ingelheim Investigational Site, Guatemala City
205.456.50205 Boehringer Ingelheim Investigational Site, Guatemala City
205.456.36005 Boehringer Ingelheim Investigational Site, Budapest
205.456.36002 Boehringer Ingelheim Investigational Site, Debrecen
205.456.36004 Boehringer Ingelheim Investigational Site, Gyula
205.456.36001 Boehringer Ingelheim Investigational Site, Miskolc
205.456.36007 Boehringer Ingelheim Investigational Site, Mosdós
205.456.36006 Boehringer Ingelheim Investigational Site, Nagyatád
205.456.97205 Boehringer Ingelheim Investigational Site, Holon
205.456.97203 Boehringer Ingelheim Investigational Site, Petah Tikva
205.456.97201 Boehringer Ingelheim Investigational Site, Safed
205.456.37101 Boehringer Ingelheim Investigational Site, Baldone
205.456.37104 Boehringer Ingelheim Investigational Site, Balvi
205.456.37103 Boehringer Ingelheim Investigational Site, Rēzekne
205.456.37102 Boehringer Ingelheim Investigational Site, Riga
205.456.37105 Boehringer Ingelheim Investigational Site, Talsi
205.456.52001 Boehringer Ingelheim Investigational Site, Hermosillo Sonora
205.456.52002 Boehringer Ingelheim Investigational Site, Monterrey
205.456.52003 Boehringer Ingelheim Investigational Site, Monterrey
205.456.52004 Boehringer Ingelheim Investigational Site, Nuevo León
205.456.09001 Boehringer Ingelheim Investigational Site, Quezon City
205.456.09002 Boehringer Ingelheim Investigational Site, Quezon City
205.456.35105 Boehringer Ingelheim Investigational Site, Coimbra
205.456.35101 Boehringer Ingelheim Investigational Site, Lisbon
205.456.35102 Boehringer Ingelheim Investigational Site, Lisbon
205.456.35104 Boehringer Ingelheim Investigational Site, Lisbon
205.456.35103 Boehringer Ingelheim Investigational Site, Porto
205.456.27001 Boehringer Ingelheim Investigational Site, Cape Town
205.456.27002 Boehringer Ingelheim Investigational Site, Durban
205.456.38006 Boehringer Ingelheim Investigational Site, Dnipropetrovsk
205.456.38004 Boehringer Ingelheim Investigational Site, Kharkiv
205.456.38003 Boehringer Ingelheim Investigational Site, Kiev
205.456.38010 Boehringer Ingelheim Investigational Site, Kryvyi Rih
205.456.38009 Boehringer Ingelheim Investigational Site, Kyiv
205.456.38001 Boehringer Ingelheim Investigational Site, Lviv
205.456.38007 Boehringer Ingelheim Investigational Site, Lviv
205.456.38005 Boehringer Ingelheim Investigational Site, Uzhhorod
205.456.38008 Boehringer Ingelheim Investigational Site, Vinnytsia
205.456.38002 Boehringer Ingelheim Investigational Site, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Boehringer Ingelheim
INDUSTRY